跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HIBERIX haemophilus influenzae type B conjugate 10microgram/0.5mL injection vial and diluent syringe - TGA Drug Approval Details
Approvals
/
TGA
/
HIBERIX haemophilus influenzae type B conjugate 10microgram/0.5mL injection vial and diluent syringe
Approved
STANDARD
HIBERIX haemophilus influenzae type B conjugate 10microgram/0.5mL injection vial and diluent syringe
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
84afa212a6dbe5b8
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
84afa212a6dbe5b8
Product Name
HIBERIX haemophilus influenzae type B conjugate 10microgram/0.5mL injection vial and diluent syringe
Artg Id
60881
Artg Name
HIBERIX haemophilus influenzae type B conjugate 10 microgram/0.5mL injection vial and diluent syringe
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
1997-10-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e79bbb04bdfe0fc71868c8a87b31e758.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f078e240f0a3497e6785de7fa84aca9d.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
84afa212a6dbe5b8
Type
Standard
Back to TGA Approvals